KZA 0.00% 8.0¢ kazia therapeutics limited

Yes spyglass, looking forward to the final data abstract...

  1. 1,135 Posts.
    lightbulb Created with Sketch. 815
    Yes spyglass, looking forward to the final data abstract publication to be presented at SNO, which should confirm the consistency of the GBM results covering the final 30 patients in the Kazia / Dana-Farber phase 11 trial.
    IMO It will be a day to remember (11/11/21.).

    Regards.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.